@article{article, title = {{Olaparib for Maintenance Treatment of BRCA 1 or 2 Mutated, Relapsed, Platinum-Sensitive Ovarian, Fallopian Tube and Peritoneal Cancer in People Whose Relapsed Disease has Responded to Platinum-Based Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal}}, url = {{https://eprints.whiterose.ac.uk/108863/ }}, year = {{2017}}, month = {{1}}, author = {{Tappenden P and Harnan S and Ren S and Thokala P and Wong R and Mukuria C and Green C and Pledge S and Tidy J}}, doi = {{10.1007/s40273-016-0440-x}}, volume = {{35}}, journal = {{PharmacoEconomics}}, issue = {{1}}, pages = {{97-109}}, note = {{Accessed on 2025/05/19}}}